Hansen Pharmaceutical: Canagliflozin tablets complete drug registration
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Hansen Pharmaceutical announced that the company recently received the "Drug Registration Certificate" for the chemical drug "Empagliflozin Tablets" issued by the National Medical Products Administration. This drug is indicated for the treatment of type 2 diabetes and for adult patients with symptomatic chronic heart failure to reduce the risk of hospitalization due to heart failure
According to the Zhitong Finance APP, Hansen Pharmaceutical (002412.SZ) announced that the company recently received the "Drug Registration Certificate" for the chemical drug "Empagliflozin Tablets" approved by the National Medical Products Administration. This drug is indicated for the treatment of type 2 diabetes and for adult patients with symptomatic chronic heart failure to reduce the risk of hospitalization due to heart failure